These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4398860)

  • 21. Diet-induced changes in subcutaneous adipose tissue blood flow in man: effect of beta-adrenoceptor inhibition.
    Simonsen L; Bülow J; Astrup A; Madsen J; Christensen NJ
    Acta Physiol Scand; 1990 Jun; 139(2):341-6. PubMed ID: 1973329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional blood flow during acute heart failure in dogs. Role of adipose tissue perfusion in regulating plasma-free fatty acids.
    Smiseth OA; Riemersma RA; Steinnes K; Mjøs OD
    Scand J Clin Lab Invest; 1983 Jun; 43(4):285-92. PubMed ID: 6635532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of beta-adrenergic blockade on coronary blood flow in the homografted canine heart.
    Boake WC; Folts JD
    Arch Int Pharmacodyn Ther; 1971 Jul; 192(1):96-104. PubMed ID: 4398413
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacological aspects of oxprenolol.
    Brunner H; Hedwall PR; Maier R; Meier M
    Postgrad Med J; 1970 Nov; ():Suppl:5-14. PubMed ID: 4395460
    [No Abstract]   [Full Text] [Related]  

  • 25. Changes in pressor activity of angiotensin II induced by pentolinium and phenobarbital in rats.
    Risler NR; Rabito SF; Ortego RE; Spitz BN; Daffra M; Binia A
    Acta Physiol Lat Am; 1974; 24(5):535-8. PubMed ID: 4377507
    [No Abstract]   [Full Text] [Related]  

  • 26. [Evaluation of myocardial relaxation in the treatment of arterial hypertension: vasodilators and beta blockers].
    Gimeno JV; Martín G; Cosín J
    Rev Esp Cardiol; 1985; 38(5):342-7. PubMed ID: 2867585
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect, in obese subjects, of the inhibition of beta-adrenergic receptors on the changes of glycemia, serum free fatty acids and glycerol, produced by glucagon].
    Milcou SM; Radian N; Dinulescou E; Dragomirescou M; Mitrache L; Isaia M
    Rev Fr Endocrinol Clin; 1970; 11(4):303-10. PubMed ID: 4397330
    [No Abstract]   [Full Text] [Related]  

  • 28. Regulation of human lipolysis. In vivo observations on the role of adrenergic receptors.
    Burns TW; Mohs JM; Langley PE; Yawn R; Chase GR
    J Clin Invest; 1974 Jan; 53(1):338-41. PubMed ID: 4808646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of non-esterified long-chain fatty acids on blood flow and thermogenesis in brown adipose tissue in the young dog.
    Astrup A; Bülow J; Christensen NJ
    Acta Physiol Scand; 1985 May; 124(1):81-5. PubMed ID: 4013787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of dl-propranolol on myocardial free fatty acid and carbohydrate metabolism.
    Masters TN; Glaviano VV
    J Pharmacol Exp Ther; 1969 May; 167(1):187-93. PubMed ID: 5772747
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of tolbutamide on blood pressure.
    Wales JK; Grant AM; Wolff FW
    J Pharmacol Exp Ther; 1971 Jul; 178(1):130-40. PubMed ID: 4325857
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of hexobendine on the content of glucose and free fatty acids in plasma under noradrenaline-infusion].
    Niessner H; Chirikdjian JJ
    Arzneimittelforschung; 1969 Jan; 19(1):62-4. PubMed ID: 5819365
    [No Abstract]   [Full Text] [Related]  

  • 33. [On the cardiovascular and beta-adrenergic blocking effects produced in the beagle dog by repeated oral administration of talinolol (Cordanum) and propranolol (author's transl)].
    Heer S; Femmer K
    Pharmazie; 1980; 34(5-6):317-20. PubMed ID: 6106208
    [No Abstract]   [Full Text] [Related]  

  • 34. Adrenoceptors mediating metabolic responses in the greyhound.
    Kelly JG; Shanks RG
    Br J Pharmacol; 1971 Feb; 41(2):389P-390P. PubMed ID: 4396705
    [No Abstract]   [Full Text] [Related]  

  • 35. [Consequences of the administration of alpha or beta drenolytic agents on the mobilization of plasma free fatty acids as induced by noradrenaline and isoprenaline in the dog].
    Berlan M
    C R Seances Soc Biol Fil; 1976 Oct; 170(3):672-9. PubMed ID: 10055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic effects of blood flow restriction in adipose tissue.
    Belfrage E; Hjemdahl P; Fredholm BB
    Acta Physiol Scand; 1979 Feb; 105(2):222-7. PubMed ID: 420021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current problems in active substance research. 4. Central effects of angiotensin II].
    Hilse H; Piesche L; Scheer E
    Pharmazie; 1974 May; 29(5):303-6. PubMed ID: 4152657
    [No Abstract]   [Full Text] [Related]  

  • 38. Pyridine nucleotides: basis for the hypotensive action of triphosphopyridine nucleotide.
    Chauhan PS; Chauhan CK; Chaudhury SK; Datta AG
    Indian J Physiol Pharmacol; 1973; 17(4):341-8. PubMed ID: 4153455
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of the hypotensive drug ST 155 (Catapres) on the heart and peripheral circulation.
    Nayler WG; Price JM; Swann JB; McInnes I; Race D; Lowe TE
    J Pharmacol Exp Ther; 1968 Nov; 164(1):45-59. PubMed ID: 5722106
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiovascular effect of sparteine in anaesthetized dogs with and without blockade of cardiac autonomic nerves.
    Schmidt HD; Padeken D; Beck L
    Arzneimittelforschung; 1986 Oct; 36(10):1481-4. PubMed ID: 2880594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.